SCHEMBL13210705

SCHEMBL13210705

N#Cc1cccc(NC(=O)c2ccc(C(=O)Nc3cccc(C#N)c3)cc2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.66
HTT P42858 1/20 0.66
NR1H4 Q96RI1 1/20 0.64
GRM4 Q14833 1/20 0.64
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
ALDH1A1 P00352 1/20 0.64
MAPT P10636 1/20 0.64
MAPK14 Q16539 3/20 0.63
F2 P00734 1/20 0.61
PLG P00747 1/20 0.61
PLAU P00749 1/20 0.61
KLKB1 P03952 1/20 0.61
PRSS1 P07477 1/20 0.61
NPC1 O15118 1/20 0.61
RAB9A P51151 1/20 0.61
P2RX1 P51575 1/20 0.59
HDAC1 Q13547 1/20 0.58
KCNK3 O14649 1/20 0.58
KCNK9 Q9NPC2 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15788186 0.95 MAPK14 (0.66) NAMPTHTTNR1H4GRM4MEN1
SCHEMBL2173418 0.93 HTT (0.71) NAMPTHTTNR1H4GRM4MEN1
SCHEMBL94618 0.92 NAMPT (0.59) NAMPTHTTNR1H4GRM4MEN1
SCHEMBL6655548 0.92 KMT2A (0.66) NAMPTHTTNR1H4GRM4MEN1
SCHEMBL14187585 0.91 PTGS1 (0.62) NAMPTHTTNR1H4GRM4MEN1
SCHEMBL7300564 0.90 NR1H4 (0.80) NAMPTHTTNR1H4GRM4MEN1
SCHEMBL666216 0.89 MAPK14 (0.74) NR1H4MEN1KMT2AALDH1A1MAPK14
SCHEMBL1247713 0.87 NPC1 (0.71) NAMPTHTTNR1H4GRM4MEN1
SCHEMBL3786489 0.85 NR1H4 (0.57) NAMPTHTTNR1H4GRM4MEN1
SCHEMBL14082881 0.85 MEN1 (0.58) NAMPTHTTNR1H4GRM4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250275537-A1 CARBOXAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE INC (US) 2025-09-04 US disclosed
US-20100204219-A1 AROMATIC 1,4-DI-CARBOXYLAMIDES AND THEIR USE THE GENETICS COMPANY, INC. (CH) 2010-08-12 US disclosed
US-20100204219-A1 AROMATIC 1,4-DI-CARBOXYLAMIDES AND THEIR USE THE GENETICS COMPANY, INC. (CH) 2010-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204219-A1 AROMATIC 1,4-DI-CARBOXYLAMIDES AND THEIR USE CBR3, CYCS, CYC1 NAMPT 3166/4885HTT 3170/4885NR1H4 759/4885
US-20250275537-A1 CARBOXAMIDE APYRASE INHIBITORS APEH, CNDP2, DNPEP NAMPT 847/4885HTT 4613/4885NR1H4 4316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.